Arrow Mark Colorado Holdings LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Arrow Mark Colorado Holdings LLC

  • $7.03 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$17.63 - $21.74 $844,529 - $1.04 Million
-47,903 Reduced 6.7%
666,976 $13.2 Million
Q4 2023

Feb 14, 2024
SELL
$14.37 - $19.07 $3.88 Million - $5.15 Million
-270,317 Reduced 27.44%
714,879 $12.5 Million
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $1.03 Million - $1.62 Million
98,326 Added 11.09%
985,196 $13.9 Million
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $1.82 Million - $2.68 Million
169,699 Added 23.66%
886,870 $9.54 Million
Q4 2022

Feb 14, 2023
SELL
$11.42 - $17.05 $2.41 Million - $3.6 Million
-210,923 Reduced 22.73%
717,171 $10.7 Million
Q3 2022

Nov 14, 2022
SELL
$9.76 - $13.41 $2.18 Million - $2.99 Million
-223,043 Reduced 19.38%
928,094 $11.9 Million
Q2 2022

Aug 15, 2022
SELL
$7.6 - $11.41 $1.29 Million - $1.94 Million
-169,840 Reduced 12.86%
1,151,137 $11.2 Million
Q1 2022

May 16, 2022
BUY
$9.3 - $12.37 $445,730 - $592,869
47,928 Added 3.76%
1,320,977 $13.1 Million
Q4 2021

Feb 14, 2022
BUY
$10.39 - $15.15 $398,965 - $581,744
38,399 Added 3.11%
1,273,049 $15 Million
Q3 2021

Nov 15, 2021
BUY
$11.39 - $16.23 $4.27 Million - $6.08 Million
374,776 Added 43.58%
1,234,650 $14.1 Million
Q2 2021

Aug 16, 2021
SELL
$13.22 - $19.09 $139,444 - $201,361
-10,548 Reduced 1.21%
859,874 $12 Million
Q1 2021

May 17, 2021
SELL
$16.68 - $23.97 $4.77 Million - $6.85 Million
-285,916 Reduced 24.73%
870,422 $16.1 Million
Q4 2020

Feb 16, 2021
SELL
$14.8 - $21.15 $43,852 - $62,667
-2,963 Reduced 0.26%
1,156,338 $20.4 Million
Q3 2020

Nov 16, 2020
BUY
$15.21 - $25.53 $17.6 Million - $29.6 Million
1,159,301 New
1,159,301 $17.8 Million
Q2 2020

Aug 14, 2020
SELL
$15.08 - $26.0 $19.2 Million - $33.1 Million
-1,274,424 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$11.0 - $19.76 $11.1 Million - $19.9 Million
-1,009,237 Reduced 44.19%
1,274,424 $19.7 Million
Q4 2019

Feb 14, 2020
BUY
$5.24 - $12.96 $1.25 Million - $3.09 Million
238,153 Added 11.64%
2,283,661 $25.3 Million
Q3 2019

Nov 14, 2019
BUY
$8.15 - $15.88 $2.13 Million - $4.15 Million
261,624 Added 14.67%
2,045,508 $17.4 Million
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.39 $2.29 Million - $3.54 Million
173,703 Added 10.79%
1,783,884 $24.2 Million
Q1 2019

May 15, 2019
BUY
$15.93 - $26.59 $5.95 Million - $9.93 Million
373,411 Added 30.19%
1,610,181 $29.1 Million
Q4 2018

Feb 14, 2019
BUY
$16.25 - $28.09 $720,622 - $1.25 Million
44,346 Added 3.72%
1,236,770 $34.7 Million
Q3 2018

Nov 14, 2018
BUY
$13.23 - $30.93 $13.8 Million - $32.2 Million
1,042,093 Added 693.2%
1,192,424 $26.5 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $2.52 Million - $3.06 Million
150,331 New
150,331 $2.61 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email